- Report
- July 2024
- 80 Pages
Japan
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- June 2024
- 85 Pages
India
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- May 2024
- 182 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- April 2024
- 180 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- February 2024
- 170 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- October 2023
- 89 Pages
Malaysia
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- October 2023
- 88 Pages
Malaysia
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- October 2023
- 83 Pages
Israel
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- October 2023
- 177 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- August 2023
- 74 Pages
United States
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- August 2023
- 112 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- April 2023
- 83 Pages
Europe
From €3053EUR$3,400USD£2,615GBP
€3592EUR$4,000USD£3,077GBP
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- February 2023
- 74 Pages
United States
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- February 2024
- 111 Pages
Global
From €4266EUR$4,750USD£3,654GBP
- Report
- April 2023
- 106 Pages
Global
From €4266EUR$4,750USD£3,654GBP
- Report
- April 2023
- 71 Pages
Italy
From €4266EUR$4,750USD£3,654GBP
- Report
- April 2023
- 110 Pages
Global
From €4266EUR$4,750USD£3,654GBP
- Report
- April 2023
- 130 Pages
Global
From €4266EUR$4,750USD£3,654GBP
- Report
- April 2023
- 146 Pages
Global
From €4266EUR$4,750USD£3,654GBP

Retinopathy is a medical condition that affects the retina, the light-sensitive tissue at the back of the eye. It is a leading cause of blindness and visual impairment worldwide. Optical treatments for retinopathy include laser photocoagulation, intravitreal injections, and vitrectomy. Laser photocoagulation is used to reduce the risk of vision loss by sealing off leaking blood vessels in the retina. Intravitreal injections are used to deliver medications directly to the retina to reduce swelling and inflammation. Vitrectomy is a surgical procedure used to remove scar tissue and other debris from the vitreous cavity.
Companies in the retinopathy market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Heidelberg Engineering, Nidek, Optos, Topcon, and Zeiss. Show Less Read more